ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 86 filers reported holding ENZO BIOCHEM INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,048,000 | +36.6% | 151,002 | +0.2% | 0.00% | 0.0% |
Q3 2016 | $767,000 | -15.0% | 150,639 | -0.3% | 0.00% | 0.0% |
Q2 2016 | $902,000 | +3010.3% | 151,049 | +2287.4% | 0.00% | – |
Q1 2016 | $29,000 | 0.0% | 6,327 | -3.1% | 0.00% | – |
Q4 2015 | $29,000 | +45.0% | 6,529 | +3.3% | 0.00% | – |
Q3 2015 | $20,000 | +5.3% | 6,318 | 0.0% | 0.00% | – |
Q2 2015 | $19,000 | -93.8% | 6,318 | -93.9% | 0.00% | – |
Q1 2015 | $306,000 | -30.9% | 103,590 | +3.9% | 0.00% | -100.0% |
Q4 2014 | $443,000 | -13.3% | 99,745 | +0.5% | 0.00% | 0.0% |
Q3 2014 | $511,000 | +0.2% | 99,281 | +2.3% | 0.00% | 0.0% |
Q2 2014 | $510,000 | – | 97,072 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARBERT FUND ADVISORS, INC. | 5,620,681 | $20,234,000 | 30.10% |
Evermore Global Advisors, LLC | 4,007,851 | $14,428,000 | 3.48% |
Fondren Management LP | 355,000 | $1,278,000 | 1.06% |
CORRADO ADVISORS, LLC | 196,309 | $707,000 | 0.64% |
MARATHON CAPITAL MANAGEMENT | 193,580 | $697,000 | 0.28% |
KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $344,000 | 0.23% |
EAM Investors, LLC | 203,962 | $734,000 | 0.19% |
Ariel Investments | 1,026,313 | $3,695,000 | 0.05% |
HighVista Strategies LLC | 19,500 | $70,000 | 0.05% |
Paradigm Financial Partners, LLC | 17,175 | $60,000 | 0.03% |